Abstract
It is only 100 years since a practical procedure for the large scale production of aluminum was developed. Since that time, aluminum has found applications in construction, electrical equipment, furnishings, transportation, containers, pharmaceuticals, and many other items encountered in daily life. Exposure to aluminum is unavoidable since it is the third most common element in the Earth’s crust, and industrial use is in the tens of millions of tons per year.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ackrill, P., Day, J.P., Garstang, F.M., Hodge, K.C., Metcalfe, P.J., Benzo, S., Hill, K., Ralston, A.J., Ball, J. and Denton, J., 1982, Treatment of fracturing renal osteodystrophy by desferrioxamine, Proc. Eur. Dial. Transplant Ass., 19: 203–207.
Ackrill, P., Kalston, A.J., Day, J.P. and Hodge, K.C., 1980, Successful removal of aluminum from a patient with dialysis encephalopathy, Lancet, i: 692–693.
Alfrey, A.C., 1978, Dialysis encephalopathy syndrome, Ann. Rev. Med., 29: 93–98.
Alfrey, A.C., LeGendre, G.R. and Kaehny, W.D., 1976, The dialysis encephalopathy syndrome. Possible aluminum intoxication, N. Engl. J. Med., 294: 184–188.
Alfrey, A.C., Mishell, J.M., Burks, J., Contiguglia, S.R., Rudolph, H., Lewin, E. and Holmes, J.H., 1972, Syndrome of dyspraxia and multifocal seizures associated with chronic haemodialysis, Trans. Am. Soc. Artif. Intern. Org., 18: 257–261.
Alfrey, A.C., Sedman, A. and Chan, Y.L., 1985, The compartmental ization and metabolism of aluminum in uremic rats, J. Lab. Clin. Med., 105: 227–233.
Andersen, A., Dahlberg, B.E., Magnus, K. and Wannag, A., 1982, Risk of cancer in the Norwegian aluminum industry, Int. J. Cancer, 29: 295–298.
Arieff, A.I., Cooper, J.D., Armstrong, D. and Lazarowitz, V.C., 1979, Dementia, renal failure and brain aluminum, Ann. Intern. Med., 90: 741–747.
Bachra, B.N. and VanHarskamp, G.A., 1970, The effect of polyvalent metal ions on the stability of a buffer system for calcification in vitro, Calcified Tissue Res., 4: 359–365.
Berland, Y., Chorhon, S.A., Olmer, M. and Meunier, P.S., 1985, Predictive value of desferrioxamine infusion test for bone aluminum deposits in hemodialyzed patients, Nephron, 40: 433–435.
Berlyne, G.M., Ben-Ari, J., Pest, D., Weinberger, J., Stern, M., Gilmore, G.R., and Levine, R., 1970, Hyperaluminaemia from aluminum resins in chronic renal failure. Lancet, ii: 494–496.
Berlyne, G.M., Yagil, R., Ben-Ari, J., Weinberger, G., Knopf, E. and Danovitch, G.M., 1972, Aluminum toxicity in rats, Lancet, i: 564–567.
Bertholf, R.L., Roman, J.M., Brown, S., Savory, J. and Wil1s, M.R., 1984, Aluminum hydroxide-induced osteomalacia, encephalopathy, and hyperaluminemia in CAPD. Treatment with desferrioxamine, Periton. Dial. Bull., 4: 30–32.
Bettinelli, M., Baroni, U., Fontana, F. and Poisetti, P., 1985, Evaluation of the L’vou platform and matrix modification for the determination of aluminum in serum, Analyst., 110: 19–22.
Betts, C.T., 1926, Aluminum Poisoning, Toledo, Research Publishing Co.
Biswas, C.K., Arze, R.S., Ramos, J.M., Ward, M.K., Dewar, J.H., Kerr, D.N.S. and Kenward, D.H., 1982, Effect of aluminum hydroxide on serum ionized calcium, immunoreactive parathyroid hormone, and aluminum in chronic renal failure, Br. Med. J., 284: 776–778.
Boyce, D.F., Fell, G.S., Elder, H.Y., Junor, B.J., Elliott, H.L., Beastall, G., Fogelman, I. and Boyle, I.T., 1982, Hypercalcaemic osteomalacia due to aluminum toxicity, Lancet, ii: 1009–1012.
Brown, D.J., Dawborn, J.K., Ham, K.N. and Xipell, J.M., 1982, Treatment of dialysis osteomalacia with desferoxamine, Lancet, ii: 343–345.
Brown, S., Bertholf, R.L., Wills, M.R. and Savory, J., 1984, Electrothermal atomic absorption spectrometric determination of aluminum in serum with a new technique for protein precipitation, Clin. Chem., 30: 1216–1218.
Burks, J.S., Alfrey, A.C., Huddlestone, J., Norenberg, M.D. and Lewin, E., 1976, A fatal encephalopathy in chronic haemodialysis patients, Lancet, i: 764–768.
Cam, J.M., Luck, Y.A., Eastwood, J.B. and De Warderner, H.E., 1976, The effect of aluminum hydroxide orally on calcium, phosphorus and aluminum metabolism in normal subjects, Clin. Sci. Mol. Med., 51: 407–414.
Canata, J.B., Briggs, J.D., Junor, B.J.R., Fell, G.S. and Beastall, G., 1983, Effect of acute aluminum overload on calcium and parathyroid-hormone metabolism, Lancet, i: 501–503.
Chan, J.C.M., Jacob, M., Brown, S., Savory, J. and Wills, M.R., 1986, Aluminum metabolism in rats, Effects of vitamin D, dihydrotachysterol, 1,25-dihydroxyvitamin D and phosphate-binders, Nephron, In press.
Chan-Yeung, M., Wong, R., Maclean, L., Tan, F., Schulzer, M., Enarson, E., Martin, A., Dennis, R. and Grzybowski, S., 1983a, Epidemiologic health study of workers in an aluminum smelter in British Columbia: Effects on the respiratory system, Ann. Rev. Respir. Pis., 127: 465–469.
Chan-Yeung, M., Wong, R., Tan, F., Enarson, D., Schulzer, M., Subbarao, K., Knickerbocker, J. and Grzybowski, S., 1983b, Epidemiologic health study of workers in an aluminum smelter in Kitimat, B.C. II. Effects on musculoskeletal and other systems, Arch. Environ. Health, 38: 34–40.
Clarkson, E.M., Luck, V.A., Hynson, W.V., Bailey, R.R., Eastwood, J.B., Woodhead, J.S., Clements, V.R., O’Riordan, J.L.H. and DeWardener, H.E., 1972, The effect of aluminum hydroxide on calcium, phosphorus and aluminum balances, the serum parathyroid hormone concentrations and the aluminum content of bone in patients with chronic renal failure, Clin. Sci., 43: 519–531.
Cournot-Witmer, G., Zingraff, J., Plachot, J.J. et al., 1981, Aluminum localization in bone from hemodialyzed patients: Relationship to matrix mineralization, Kidney Int., 20: 375–385.
Davison, A.M., Walker, G.S., Ott, H. and Lewis, A.M., 1982, Water supply aluminum concentration, dialysis dementia, and effect of reverse-osmosis water treatment, Lancet, ii: 785–787.
Day, J.P., Ackrill, P., Garstand, F.M., Hodge, K.C. and Metcalfe, P.J., 1983, Reduction of the body burden of aluminum in renal patients by desferoxamine chelation therapy, in: “Chemical Toxicology and Clinical Chemistry of Metals”, S.S. Brown and J. Savory, eds., pp. 353–356, Academic Press, London.
DeHamel, F., 1983, Aluminum smelters and health, N. Z. Med. J., 1: 123.
De Vernejoul, M.C., Marchais, S., London, G., Morieux, C., Bielakoff, J. and Miravett, L., 1985, Increased bone aluminum deposition after subtotal parathyroidectomy in dialyzed patients, Kidney Int., 27: 785–791.
Disler, P., Day, R., Burman, N., bickkenhorst, G. and Eales, L., 1982, Treatment of hemodialysis-related porphyria cutanea tarda with plasma exchange, Am. J. Med., 72: 989–993.
Drueke, T., 1980, Dialysis osteomalacia and aluminum intoxication, Nephron, 26: 207–210.
Drummond, J.L., Simon, M.R., Woodman, J.L. and Brown, S.D., 1983, Aluminum ion deposition in rat tissues following implantation of a ceramic metal disc., Biomat. Med. Dev. Art. Org., 11: 147–159.
Elinder, C.G. and Sjogren, B., 1986, Aluminum, in: “Handbook on the Toxicology of Metals,” 2nd Ed., L. Friberg, G.F. Nordberg, V.B. Vouk, eds., pp. 1–25, Elsevier/North Holland Biomedical Press, Amsterdam.
Elliott, H.L. and MacDougall, A.I., 1978, aluminum studies in dialysis encephalopathy, Proc. EDTA, 15: 157–163.
Elliott, H.L., MacDougall, A.I.. and Fell, G.S., 1978, Aluminum toxicity syndrome, Lancet, 1: 1203.
Feinroth, M., Feinroth, M.V. and Berlyne, G.M., 1982, Aluminum absorption in the rat everted gut sac, Mineral Electrolyte Metabl., 8: 29–35.
Finch, C.A. and Hubers, H., 1982, Perspectives in iron metabolism, New Engl. J. Med., 306: 1520–1528.
Flendrig, J.A., Kruis, H. and Das, H.A., 1976, Aluminum and dialysis dementia, Lancet, i: 1235.
Garruto, R.M., Fukatsu, R., Yanagihara, R., Gajdusek, D.C., Hook, G. and Fiori, C.E., 1984, Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in Parkinsonism-dementia of Guam, Proc. Natl. Acad. Sci. U.S.A., 81: 1875–1879.
Gorsky, J.E., Dietz, A.A., Spencer, H. and Osis, D., 1979, Metabolic balance of aluminum studied in six men, Clin. Chem., 25: 1739–1743.
Greger, J.L. and Baier, M.J., 1983a, Excretion and retention of low or moderate levels of aluminum by human subjects, Fd. Chem. Toxic., 21: 473–477.
Greger, J.L. and Baier, M.J., 1983b, effect of dietary aluminum on mineral metabolism of adult males, Am. J. Clin. Nutr., 38: 411–419.
Griswold, W.R., Reznik, V., Mendoza, A., Trauner, D. and Alfrey, A.C., 1983, Accumulation of aluminum in a non-dialyzed uremic child receiving aluminum hydroxide, Pediatrics, 71: 56–58.
Henry, D.A., Nudelman, R.K., DiDomenico, N.C., Stanley, T.M., Alfrey, A.C., Goodman, W.G., Slatotolsky, E. and Coburn, J.W., 1982, Metabolic and toxic effects of aluminum in the dog, Kidney Int., 21: 229.
Hirschberg, R., Von Hermath, D., Voss, R., Bossaller, W., Mavelshagen, V., Pauls, A. and Schaefer, K., 1985, Organ distribution of aluminum in uremic rats: Influence of parathyroid hormone and 1–25-dihydroxyvitamin D3, Min. Elect. Metab., 11: 106–110.
Hodsman, A.B., Sherrard, D..H., Alfrey, A.C., Ott, S., Brickman, A.S., Miller, N.L. and Coburn, J.W., 1982, Bone aluminum and histomorphometric features of renal osteodystrophy, J. Clin. Endocrinol. Metab., 54: 539–546.
Jackson, M.L. and Huang, P.M., 1983, Aluminum of acid soils in the food chain and senility, Sci. Tot. Environ., 28: 269–276.
Kanis, J.A., 1981, Osteomalacia and chronic renal failure, J. Clin. Pathol., 34: 1295–1307.
Kappel, L.C., Youngberg, H., Ingraham, R.H., Hembry, F.G., Robinson, D.L. and Cherney, J.H., 1983, Effects of dietary aluminum on magnesium status of cows, Am. J. Res., 44: 770–773.
Kingswood, C., Banks, R.A., Bunker, T., Harrison, P. and MacKenzie, C., 1983, Fracture osteomalacia, CAPD and aluminum, Lancet, i: 70–71.
Koning, J.H., 1981, Aluminum pots as a source of dietary aluminum, N. Engl. J. Med., 304: 172.
Kovalchik, M.T., Kaehing, W.D., Hegg, A.P., Jackson, J.T. and Alfrey, A.C., 1978, Aluminum kinetics during hemodialysis, J. Lab. Clin. Med., 712–720.
Leung, F.Y. and Henderson, A.R., 1982, Improved determination of aluminum in serum and urine with use of a stabilized temperature platform furnace, Clin. Chem., 28: 2139–2143.
Levick, S.E., 1980, Dementia from aluminum pots, N. Engl. J. Med., 303: 164.
Lione, A., 1984, Aluminum in food, Nutr. Rev., 42: 31.
Manis, J.G. and Schachter, D.L., 1962, Active transport of iron by intestine: Features of the two-step mechanism, Am. J. Physiol., 203: 73–78.
Mauras, Y., Allain, P. and Riberi, P., 1982, Etude de l’absorption digestive de l’hydrocarbonate d’aluminium chez l’individu sain, Therapie, 37: 593–605.
Mayor, G.B., Sprague, S.M. and Sanchez, T.V., 1981, Determinants of tissue aluminum concentration, Am. J. Kidney Pis., 1: 141–145.
McDermott, J.R., Smith, I.A., Iqbal, K. and Wisniewski, H.M., 1979, Brain aluminum in aging and Alzheimer disease, Neurology, 29: 809–814.
McKinney, T.D., Basinger, M., Dawson, E. and Jones, M.M., 1982, Serum aluminum levels in dialysis dementia, Nephron, 32: 53–56.
McLaughlin, A.I.G., Kazantzis, G., King, E., Teare, D., Porter, R.J. and Owen, R., 1962, Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminum dust, Br. J. Industr. Med., 19: 253–263.
Miller, R.G., Kopfler, F.C., Kelty, K.C., Stober, J.A. and ulmer, N.S., 1984, The occurrence of aluminum in drinking water, J. Am. Mater Works Assn., 76: 84–91.
Milliner, D.S., Nebeker, H.G., Ott, S.M., Andress, D.L., Sherrard, D.J., Alfrey, A.C., Spatopolsky, E.A. and Coburn, J.W., 1984, Use of the deferroxomine infusion test in the diagnosis of aluminum-related osteodystrophy, Am. Int. Med., 101: 775–780.
Nathan, E. and Pedersen, S., 1980, Dialysis encephalopathy in a non-dialyzed uraemic boy treated with aluminum hydroxide orally, Acta Paediatr. Scand., 69: 793–796.
Ondreicka, R., Ginter, E. and Kortus, J., 1966, Chronic toxicity of aluminum in rats and mice and its effects on phosphorus metabolism, Brit. J. Int. Med., 23: 305–312.
Ott, S.M., Maloney, N.A., Coburn, J.W.? Alfrey, A.C. and Sherrard, D.J., 1982, The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitroil therapy, N. Engl. J. Med., 307: 709–713.
Parkinson, I.S., Ward, M.K. and Kerr, D.N.S., 1981, Dialysis encephalopathy, bone disease and anemia: The aluminum intoxication syndrome during regular haemodialysis, J. Clin. Pathol., 34: 1285–1294.
Perl, D.P. and Brody, A.R., 1980, Alzheimer’s disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons, Science, 208: 297–299.
Perl, D.P., Gajdusek, D.C., Garruto, R.M., Yanagihara, R.T. and Gibbs, C.J., Jr., 1982, Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam, Science, 217: 1053–1055.
Perl, D.P. and Pendlebury, W.W., 1984, Aluminum (Al) accumulation in neurofibrillary tangle (NFT) bearing neurons of senile dementia Alzheimer’s type (SDAT); Detection by intraneuronal x-ray spectrometry studies of unstained tissue sections, J. Neuropathol. Exp. Pathol., 43: 349.
Prior, J.C., Cameron, E.C., Nickerbocker, W.J., Sweeney, V.P. and Suchowersky, O., 1982, Dialysis encephalopathy and osteomalacia bone disease, A case-controlled study, Am. J. Med., 72: 33–42.
Robertson, J.A., Felsenfeld, A.J., Haygood, C.C., Wilson, P., Clarke, C. and Llach, F., 1983, Animal model of aluminum-induced osteomalacia: Role of chronic renal failure. Kidney Int., 23: 327–335.
Rockette, H.E. and Arena, A.C., 1983, Mortality studies of aluminum reduction plant workers: Potroom and carbon department, J. Occ. Med., 25: 549–557.
Savory, J., Berlin, A., Courtoux, C., Yeoman, B. and Wills, M.R., 1983, Summary report of an international workshop on “The role of biological monitoring in the prevention of aluminum toxicity in man: Aluminum analysis in biological fluids”, Ann. Clin. Lab. Sci., 13: 444–451.
Savory, J. and Wills, M.R., 1986, Analytical methods for aluminum measurement, Kidney Int., 29: 524–527.
Shore, D. and Wyatt, R.J., 1983, Aluminum and Alzheimer’s disease, J. Nerv. Ment. Pis., 171: 553–558.
Skalsky, H. L. and Carchman, R.A., 1983, Aluminum homeostasis in man, J. Am. College Toxicol., 2: 405–423.
Siderman, S. and Manor, D., 1982, The dialysis dementia syndrome and aluminum intoxication, Nephron, 31: 1–10.
Simpson, W., Kerr, D.N.S., hill, A.V.L. and Siddiqui, J.Y., 1973, Skeletal changes in patients on regular hemodialysis, Radiology, 107: 313–320.
Sjogren, B., Lundberg, I. and Lidums, V., 1983, Aluminum in the blood and urine of industrially exposed workers, Br. J. Ind. Med., 40: 301–304.
Slanina, P., Falkeborn, Y., Freeh, W. and Cedergren, A., 1984, Aluminum concentrations in the brain and bone of rats fed citric acid, aluminum citrate and aluminum hydroxide, Fd. Chem. Toxic., 22: 391–397.
Smith, D.B., Lewis, J.A., Burks, J.S. and Alfrey, A.C., 1980, Dialysis encephalopathy in peritoneal dialysis, J. Amer. Medic. Assn. Sorenson, J.R.J., Campbell, I.R., Tepper, L.B. and Lingg, R.D., 1974, Aluminum in the environment and human health, Environ. Health Persp., 8: 3–95.
Spencer, H. and Lender, M., 1979, Adverse effects of aluminum-containing antacids on mineral metabolism, Gastroenterol., 86: 603–606.
Spofforth, J., 1921, Case of aluminum poisoning, Lancet, i: 1301.
Sunderman, F.W., Jr., Marzouk, A., Crisostomo, M.C. and Weatherby, D.R., 1985, Electrothermal atomic absorption spectrophotometry of nickel in tissue homogenates, Ann. Clin. Lab. Sci., 15: 299–307.
Tatler, G.L.V.., Baillod, R.A., Yarghese, Z., Yong, W.B., Farrow, S., Wills, M.R. and Moorhead, J.F., 1973, Evolution of bone disease over 10 years in 135 patients with terminal renal failure, Br. Med. J., iii: 315–319.
Thornton, D.J., Liss, L. and Lott, J.A., 1983, Effect of ethanol on the uptake and distribution of aluminum in rats, Clin. Chem., 29: 1281.
Trapp, G.A. and Cannon, J.B., 1981, Aluminum pots as a source of dietary aluminum, N. Engl. J. Med., 304: 172–173.
Van der Voet, G.B. and De Wolff, F.A., 1984, A method of studying the intestinal absorption of aluminum in the rat, Arch. Toxicol., 55: 168–172.
Varghese, Z., Moorhead, J.F. and Wills, M.R., 1973, Plasma calcium and magnesium fractions in chronic renal failure patients on maintenance haemodialysis, Lancet, ii: 985–988.
Versieck, J. and Cornell’s, R., 1980, Normal levels of trace elements in human blood plasma or serum, Anal. Chim. Acta, 116: 217–254.
Walker, G.S., Aaron, J.E., Peacock, M., Robinson, P.J.A. and Davison, A.M., 1982, Dialysate aluminum concentration and renal bone disease, Kidney Int., 21: 411–415.
Wills, M.R., 1973, Intestinal absorptions of calcium, Lancet, i: 820–823.
Wills, M.R., 1978, “Metabolic Consequence of Chronic Renal Failure”, 2nd Ed., Harvey Miller and Medcalf, Aylesbury.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Savory, J., Wills, M.R. (1988). Biological Monitoring of Aluminum. In: Clarkson, T.W., Friberg, L., Nordberg, G.F., Sager, P.R. (eds) Biological Monitoring of Toxic Metals. Rochester Series on Environmental Toxicity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0961-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0961-1_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-42809-8
Online ISBN: 978-1-4613-0961-1
eBook Packages: Springer Book Archive